Serek Tekin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Serek Tekin has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Erbil Seven
Department of Ophthalmology, Faculty of Medicine, Van Yüzüncü Yil University, Van, Turkey
14 shared publications - Muhammed Batur
Urartu Eye Center, 65080 Van, Turkey
10 shared publications - Muhammet Derda Ozer
Ophthalmology Department, Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey
7 shared publications - Tekin Yasar
University of Health Sciences, Beyoglu Eye Training and Research Hospital, Istanbul, Turkey
3 shared publications - Veysi Yıldız
Department of Ophthalmology, Medical Faculty, Yuzuncu Yıl University, 65090 Van, Turkey
3 shared publications - Fatih Kebapci
Faculty of Medicine, Ophthalmology Department, Van Yuzuncu Yil University, Van, Turkey
2 shared publications
Latest Publications
- 10 September 2026
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- p. 1-14
Association between choroidal vascularity index and disease activity in Behçet uveitis using BOS24 and FFA scores
Purpose To compare the choroidal vascularity index (CVI) between eyes with Behçet uveitis and healthy control eyes and to evaluate its relationship with clinical and angiographic disease activity. Methods This retrospective cross-sectional study included 66 eyes of 36 patients with Behçet uveitis and 60 eyes of 30 healthy participants evaluated between April 2022 and April 2024. CVI was calculated from total choroidal and luminal area measurements obtained from three 9-mm horizontal enhanced-depth imaging optical coherence tomography scans. Clinical activity was assessed using the Behçet’s Disease Ocular Attack Score 24 (BOS24), a 24-point composite score incorporating anterior chamber cells, vitreous haze, and newly developed posterior-segment inflammatory lesions. Angiographic activity was assessed using a modified Angiography Scoring for Uveitis Working Group system based on fundus fluorescein angiography (FFA) findings. Generalized estimating equations were used to account for inter-eye correlation. Results Mean CVI was significantly lower in eyes with Behçet uveitis than in healthy control eyes (p = 0.001), despite comparable central macular and subfoveal choroidal thickness. BOS24-active eyes had significantly lower CVI and luminal area values than BOS24-inactive eyes (p ≤ 0.005). Although CVI values tended to be lower in FFA-active eyes, most differences were not statistically significant. The lowest CVI values were observed in eyes with concurrent clinical and angiographic activity (FFA+/BOS24+). BOS24-defined peripheral new lesions were the only variable independently associated with lower mean CVI (β = −0.162, p = 0.024). Conclusion CVI was lower in Behçet uveitis despite comparable choroidal thickness, indicating alterations in choroidal luminal–stromal composition that were not reflected by thickness measurements alone. Its relationship with BOS24-defined clinical activity was more evident than that with FFA-defined activity. The observed CVI pattern may reflect the combined effects of current inflammation and cumulative vascular remodeling. These findings position CVI as a promising noninvasive structural biomarker that may complement conventional clinical and angiographic assessments of choroidal involvement in Behçet uveitis.
- 10 September 2026
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- p. 1-14
Association between choroidal vascularity index and disease activity in Behçet uveitis using BOS24 and FFA scores
Purpose To compare the choroidal vascularity index (CVI) between eyes with Behçet uveitis and healthy control eyes and to evaluate its relationship with clinical and angiographic disease activity. Methods This retrospective cross-sectional study included 66 eyes of 36 patients with Behçet uveitis and 60 eyes of 30 healthy participants evaluated between April 2022 and April 2024. CVI was calculated from total choroidal and luminal area measurements obtained from three 9-mm horizontal enhanced-depth imaging optical coherence tomography scans. Clinical activity was assessed using the Behçet’s Disease Ocular Attack Score 24 (BOS24), a 24-point composite score incorporating anterior chamber cells, vitreous haze, and newly developed posterior-segment inflammatory lesions. Angiographic activity was assessed using a modified Angiography Scoring for Uveitis Working Group system based on fundus fluorescein angiography (FFA) findings. Generalized estimating equations were used to account for inter-eye correlation. Results Mean CVI was significantly lower in eyes with Behçet uveitis than in healthy control eyes (p = 0.001), despite comparable central macular and subfoveal choroidal thickness. BOS24-active eyes had significantly lower CVI and luminal area values than BOS24-inactive eyes (p ≤ 0.005). Although CVI values tended to be lower in FFA-active eyes, most differences were not statistically significant. The lowest CVI values were observed in eyes with concurrent clinical and angiographic activity (FFA+/BOS24+). BOS24-defined peripheral new lesions were the only variable independently associated with lower mean CVI (β = −0.162, p = 0.024). Conclusion CVI was lower in Behçet uveitis despite comparable choroidal thickness, indicating alterations in choroidal luminal–stromal composition that were not reflected by thickness measurements alone. Its relationship with BOS24-defined clinical activity was more evident than that with FFA-defined activity. The observed CVI pattern may reflect the combined effects of current inflammation and cumulative vascular remodeling. These findings position CVI as a promising noninvasive structural biomarker that may complement conventional clinical and angiographic assessments of choroidal involvement in Behçet uveitis.
- Open Access
Serum Markers of Oxidative Stress and Antioxidant Status in Keratoconus: Ischemia-Modified Albumin, Malondialdehyde, and Total Thiol Levels
Background and Objectives: Keratoconus (KC) is a progressive corneal ectatic disorder characterized by stromal thinning, irregular astigmatism, and visual impairment. Increasing evidence suggests that oxidative stress plays a significant role in the pathogenesis of KC. Biomarkers such as ischemia-modified albumin (IMA), malondialdehyde (MDA) and total thiol (TT) have been widely used to assess oxidative status. This study aims to evaluate the role of oxidative stress in KC disease by comparing serum levels of IMA, MDA, and TT between KC patients and healthy controls. Material and Methods: Forty patients diagnosed with KC and 43 healthy individuals of similar age and gender were included in the study. Patients with KC were classified in 4 stages according to the modified Krumeich KC classification system. IMA, MDA, and TT levels were compared in serum samples from patient and control groups. Results: Serum IMA levels were 2.52 ± 0.07 in the KC group and 1.2 ± 0.03 in the control group. The difference was statistically significant (p < 0.001). While serum MDA levels were 1.68 ± 0.05 in the KC group, they were 0.74 ± 0.04 in the control group. The difference was statistically significant (p < 0.001). Serum TT levels were 0.82 ± 0.41 in the KC group and 2.23 ± 0.04 in the control group. The difference was statistically significant (p < 0.001). Conclusions: Elevated serum IMA and MDA levels, together with decreased TT levels, in patients with KC are likely associated with increased oxidative stress. These parameters may serve as auxiliary biomarkers for evaluating disease pathophysiology and may represent potential targets for future diagnostic and therapeutic strategies.
Open AccessSerum Markers of Oxidative Stress and Antioxidant Status in Keratoconus: Ischemia-Modified Albumin, Malondialdehyde, and Total Thiol Levels
Background and Objectives: Keratoconus (KC) is a progressive corneal ectatic disorder characterized by stromal thinning, irregular astigmatism, and visual impairment. Increasing evidence suggests that oxidative stress plays a significant role in the pathogenesis of KC. Biomarkers such as ischemia-modified albumin (IMA), malondialdehyde (MDA) and total thiol (TT) have been widely used to assess oxidative status. This study aims to evaluate the role of oxidative stress in KC disease by comparing serum levels of IMA, MDA, and TT between KC patients and healthy controls. Material and Methods: Forty patients diagnosed with KC and 43 healthy individuals of similar age and gender were included in the study. Patients with KC were classified in 4 stages according to the modified Krumeich KC classification system. IMA, MDA, and TT levels were compared in serum samples from patient and control groups. Results: Serum IMA levels were 2.52 ± 0.07 in the KC group and 1.2 ± 0.03 in the control group. The difference was statistically significant (p < 0.001). While serum MDA levels were 1.68 ± 0.05 in the KC group, they were 0.74 ± 0.04 in the control group. The difference was statistically significant (p < 0.001). Serum TT levels were 0.82 ± 0.41 in the KC group and 2.23 ± 0.04 in the control group. The difference was statistically significant (p < 0.001). Conclusions: Elevated serum IMA and MDA levels, together with decreased TT levels, in patients with KC are likely associated with increased oxidative stress. These parameters may serve as auxiliary biomarkers for evaluating disease pathophysiology and may represent potential targets for future diagnostic and therapeutic strategies.
- 5 January 2026
- Published by Taylor & Francis in Current Eye Research
- Vol. 51 (4) , 413-423
Efficacy of Bakuchiol in a Rat Model of Chemical Eye Injury
To evaluate the therapeutic effects of bakuchiol on clinical and histopathological outcomes in a rat model of corneal alkali burn. Corneal alkali burns were induced in the right eyes of 35 male Wistar rats, which were randomized into five groups: control, carbomer, steroid, 0.14 mg/g bakuchiol, and 0.28 mg/g bakuchiol. Examinations were performed under stereomicroscopy with intraperitoneal ketamine anesthesia on days 0, 3, 7, and 14 to assess corneal epithelial defects and opacity; on day 14, corneal neovascularization was additionally evaluated. After the final examination, the eyes were enucleated, and the corneas were processed for hematoxylin-eosin and immunohistochemical staining. Epithelial necrosis, inflammatory cell density, corneal hemorrhage, stromal edema, and staining intensity for VEGF and TNF-α were semi-quantitatively scored. Bakuchiol treatment, particularly at 0.28 mg/g, significantly reduced corneal opacity, neovascularization, hemorrhage, and stromal edema compared with the steroid-treated group. Bakuchiol demonstrated promising anti-inflammatory and anti-angiogenic effects and may represent a potential adjunctive treatment for corneal chemical injuries.
- 5 January 2026
- Published by Taylor & Francis in Current Eye Research
- Vol. 51 (4) , 413-423
Efficacy of Bakuchiol in a Rat Model of Chemical Eye Injury
To evaluate the therapeutic effects of bakuchiol on clinical and histopathological outcomes in a rat model of corneal alkali burn. Corneal alkali burns were induced in the right eyes of 35 male Wistar rats, which were randomized into five groups: control, carbomer, steroid, 0.14 mg/g bakuchiol, and 0.28 mg/g bakuchiol. Examinations were performed under stereomicroscopy with intraperitoneal ketamine anesthesia on days 0, 3, 7, and 14 to assess corneal epithelial defects and opacity; on day 14, corneal neovascularization was additionally evaluated. After the final examination, the eyes were enucleated, and the corneas were processed for hematoxylin-eosin and immunohistochemical staining. Epithelial necrosis, inflammatory cell density, corneal hemorrhage, stromal edema, and staining intensity for VEGF and TNF-α were semi-quantitatively scored. Bakuchiol treatment, particularly at 0.28 mg/g, significantly reduced corneal opacity, neovascularization, hemorrhage, and stromal edema compared with the steroid-treated group. Bakuchiol demonstrated promising anti-inflammatory and anti-angiogenic effects and may represent a potential adjunctive treatment for corneal chemical injuries.
- Open Access
- 8 May 2025
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 31, e948665
Comparative Analysis of Oxidative Stress Biomarkers in 50 Primary Open-Angle Glaucoma Patients
Comparative Analysis of Oxidative Stress Biomarkers in 50 Primary Open-Angle Glaucoma Patients - Article abstract #948665
- 8 May 2025
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 31, e948665
Open AccessComparative Analysis of Oxidative Stress Biomarkers in 50 Primary Open-Angle Glaucoma Patients
Comparative Analysis of Oxidative Stress Biomarkers in 50 Primary Open-Angle Glaucoma Patients - Article abstract #948665
- 17 April 2025
- Published by MediHealth Academy in Archives of Ophthalmological Research
- Vol. 2 (2) , 33-35
Evaluation of the efficacy of argon laser photocoagulation therapy in patients with retinal tear
Aims: To report the clinical results of argon laser photocoagulation treatment of patients diagnosed in our clinic with retinal tears and/or holes. Methods: Argon laser photocoagulation 0.1-0.2 sec, 200-400 µm spot size in 3-4 rows around the lesion and 250-500 millijoule power) treatment results of patients with retinal tears and/or holes who were treated and followed up in our clinic's retina unit were evaluated retrospectively. Results: During the follow-up period, 61 eyes of 57 patients were treated with argon laser photocoagulation. The success rate of the treatment in retinal detachment prophylaxis was 89.5%. Visual functions improved or remained stable in 82.5% of the patients after argon laser retinopexy. No increase in intraocular pressure or laser-related side effects were observed in any patient during the follow-up period. Conclusion: Argon laser photocoagulation is a safe and effective method for retinal tears and holes. According to our clinical experience, it can be safely applied in the prevention of retinal detachment.
- 17 April 2025
- Published by MediHealth Academy in Archives of Ophthalmological Research
- Vol. 2 (2) , 33-35
Evaluation of the efficacy of argon laser photocoagulation therapy in patients with retinal tear
Aims: To report the clinical results of argon laser photocoagulation treatment of patients diagnosed in our clinic with retinal tears and/or holes. Methods: Argon laser photocoagulation 0.1-0.2 sec, 200-400 µm spot size in 3-4 rows around the lesion and 250-500 millijoule power) treatment results of patients with retinal tears and/or holes who were treated and followed up in our clinic's retina unit were evaluated retrospectively. Results: During the follow-up period, 61 eyes of 57 patients were treated with argon laser photocoagulation. The success rate of the treatment in retinal detachment prophylaxis was 89.5%. Visual functions improved or remained stable in 82.5% of the patients after argon laser retinopexy. No increase in intraocular pressure or laser-related side effects were observed in any patient during the follow-up period. Conclusion: Argon laser photocoagulation is a safe and effective method for retinal tears and holes. According to our clinical experience, it can be safely applied in the prevention of retinal detachment.
- Open Access
Evaluation of Anatomical Measurements of the Bulbus Oculi by Optical Biometry in the Eastern Region of Türkiye
Background and Objectives: The objective was to assess ocular biometric measurements in relation to age and gender among patients scheduled for cataract surgery, utilizing an optical biometry device. Materials and Methods: The optical biometric parameters evaluated included axial length (AL), central corneal thickness (CCT), anterior chamber depth (AD), lens thickness (LT), horizontal corneal diameter (WTW), and keratometry values in the flat (K1) and steep (K2) meridians. Astigmatism (AST) was also measured as the difference between these keratometry values. Results: A total of 14,183 optical biometric measurements were included in the study. The average age of the participants was determined to be 56 (3–110) years. The average AL was 23.57 ± 1.45 mm, the average AD was 2.76 ± 0.42 mm, the average CCT was 518.13 ± 37.81 μm, the average WTW distance was 11.88 ± 0.59 mm, and the average LT was 4.19 ± 0.51 mm. The keratometry measurements were recorded as K1 = 43.39 ± 1.96 diopters (D), K2 = 44.51 ± 2.31 D, and AST = 1.12 ± 1.15 D. The average values for male eyes in terms of the AL, AD, WTW, and LT measurements were significantly higher than those for female eyes (p = 0.001). The average K1 and K2 values were flatter in males than in females, while the AST value was found to be higher in females (p = 0.001). As age progressed, the mean AL decreased, the CCT decreased, the AD narrowed, the WTW distance decreased, the LT increased, and the keratometric values K1, K2, and AST decreased until the age of 60, after which they increased again. Conclusions: Research indicates that the measurements of the bulbus oculi are generally larger in males than in females. Furthermore, each of the optical biometric measurements is interrelated. Over time, these measurements may change.
Open AccessEvaluation of Anatomical Measurements of the Bulbus Oculi by Optical Biometry in the Eastern Region of Türkiye
Background and Objectives: The objective was to assess ocular biometric measurements in relation to age and gender among patients scheduled for cataract surgery, utilizing an optical biometry device. Materials and Methods: The optical biometric parameters evaluated included axial length (AL), central corneal thickness (CCT), anterior chamber depth (AD), lens thickness (LT), horizontal corneal diameter (WTW), and keratometry values in the flat (K1) and steep (K2) meridians. Astigmatism (AST) was also measured as the difference between these keratometry values. Results: A total of 14,183 optical biometric measurements were included in the study. The average age of the participants was determined to be 56 (3–110) years. The average AL was 23.57 ± 1.45 mm, the average AD was 2.76 ± 0.42 mm, the average CCT was 518.13 ± 37.81 μm, the average WTW distance was 11.88 ± 0.59 mm, and the average LT was 4.19 ± 0.51 mm. The keratometry measurements were recorded as K1 = 43.39 ± 1.96 diopters (D), K2 = 44.51 ± 2.31 D, and AST = 1.12 ± 1.15 D. The average values for male eyes in terms of the AL, AD, WTW, and LT measurements were significantly higher than those for female eyes (p = 0.001). The average K1 and K2 values were flatter in males than in females, while the AST value was found to be higher in females (p = 0.001). As age progressed, the mean AL decreased, the CCT decreased, the AD narrowed, the WTW distance decreased, the LT increased, and the keratometric values K1, K2, and AST decreased until the age of 60, after which they increased again. Conclusions: Research indicates that the measurements of the bulbus oculi are generally larger in males than in females. Furthermore, each of the optical biometric measurements is interrelated. Over time, these measurements may change.
- 11 July 2023
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 43, 103704
The role of anterior segment optical coherence tomography in the evaluation of the pterygium
- 11 July 2023
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 43, 103704
The role of anterior segment optical coherence tomography in the evaluation of the pterygium
- 25 July 2022
- Published by Academician Publishing
- p. 37-54
Sirkadiyen Ritim Düzenleyiciler, Işık ve Göz Hastalıkları
Sirkadiyen ritim, siyanobakterilerden insanlara kadar geniş bir yelpazede tanımlanan, yaklaşık 24 saatlik periyotlarla kendini tekrar eden endojen biyolojik süreçleri ifade etmektedir. Memelilerde bu sistemin ana hiyerarşik düzenleyicisi suprakiyazmatik nükleus (SKN) olup, periferik doku ve organlardaki saatleri nöronal ve hormonal yollar aracılığıyla senkronize eder. Sirkadiyen zamanlamanın ayarlanmasında en baskın dış uyaran ışık iken, temel endokrin çıktı sinyali ise gece sentezi artan melatonin hormonudur. Başta oküler yüzey ve retina olmak üzere gözün birçok anatomik bölümünde melatonin reseptörleri bulunmakta ve bu döngü oküler fizyolojinin sürdürülmesinde kritik roller oynamaktadır. Zamanlama sistemindeki bozulmalar; kuru göz, korneal yara iyileşmesinde gecikme, glokom, miyopi, katarakt ve diyabetik retinopati gibi çeşitli göz hastalıklarının patogeneziyle yakından ilişkilidir. Örneğin glokom hastalarında gece göz içi basıncı dalgalanmaları ve melatonine karşı olası bir direnç gözlenirken, açık havada yüksek ışığa maruz kalmanın dopamin ve melatonin salınımını etkileyerek miyopi gelişimini azalttığı saptanmıştır. Sonuç olarak, göz hastalıklarının tanı ve tedavisinde sirkadiyen ritmin 24 saatlik takibi ve melatonin analoglarının terapötik kullanımı, klinik yaklaşımlar için güçlü gelecek hedefleri sunmaktadır. Circadian rhythms represent endogenous biological processes with a period of approximately 24 hours, observed across a wide spectrum from cyanobacteria to humans. In mammals, the primary hierarchical pacemaker of this system is the suprachiasmatic nucleus (SCN), which synchronizes clocks in peripheral tissues and organs through neuronal and hormonal pathways. While light is the most dominant environmental cue in adjusting circadian timing, melatonin, whose synthesis increases at night, serves as the fundamental endocrine output signal. Melatonin receptors are present in many anatomical sections of the eye, particularly the ocular surface and retina, and this cycle plays critical roles in maintaining ocular physiology. Disruptions in the timing system are closely associated with the pathogenesis of various ocular diseases, such as dry eye, delayed corneal wound healing, glaucoma, myopia, cataracts, and diabetic retinopathy. For instance, while glaucoma patients exhibit nocturnal intraocular pressure fluctuations and potential resistance to melatonin, exposure to high outdoor light has been found to reduce myopia development by influencing dopamine and melatonin release. Consequently, the 24-hour monitoring of circadian rhythms and the therapeutic use of melatonin analogues in the diagnosis and treatment of ocular diseases offer potent future targets for clinical approaches.
- 25 July 2022
- Published by Academician Publishing
- p. 37-54
Sirkadiyen Ritim Düzenleyiciler, Işık ve Göz Hastalıkları
Sirkadiyen ritim, siyanobakterilerden insanlara kadar geniş bir yelpazede tanımlanan, yaklaşık 24 saatlik periyotlarla kendini tekrar eden endojen biyolojik süreçleri ifade etmektedir. Memelilerde bu sistemin ana hiyerarşik düzenleyicisi suprakiyazmatik nükleus (SKN) olup, periferik doku ve organlardaki saatleri nöronal ve hormonal yollar aracılığıyla senkronize eder. Sirkadiyen zamanlamanın ayarlanmasında en baskın dış uyaran ışık iken, temel endokrin çıktı sinyali ise gece sentezi artan melatonin hormonudur. Başta oküler yüzey ve retina olmak üzere gözün birçok anatomik bölümünde melatonin reseptörleri bulunmakta ve bu döngü oküler fizyolojinin sürdürülmesinde kritik roller oynamaktadır. Zamanlama sistemindeki bozulmalar; kuru göz, korneal yara iyileşmesinde gecikme, glokom, miyopi, katarakt ve diyabetik retinopati gibi çeşitli göz hastalıklarının patogeneziyle yakından ilişkilidir. Örneğin glokom hastalarında gece göz içi basıncı dalgalanmaları ve melatonine karşı olası bir direnç gözlenirken, açık havada yüksek ışığa maruz kalmanın dopamin ve melatonin salınımını etkileyerek miyopi gelişimini azalttığı saptanmıştır. Sonuç olarak, göz hastalıklarının tanı ve tedavisinde sirkadiyen ritmin 24 saatlik takibi ve melatonin analoglarının terapötik kullanımı, klinik yaklaşımlar için güçlü gelecek hedefleri sunmaktadır. Circadian rhythms represent endogenous biological processes with a period of approximately 24 hours, observed across a wide spectrum from cyanobacteria to humans. In mammals, the primary hierarchical pacemaker of this system is the suprachiasmatic nucleus (SCN), which synchronizes clocks in peripheral tissues and organs through neuronal and hormonal pathways. While light is the most dominant environmental cue in adjusting circadian timing, melatonin, whose synthesis increases at night, serves as the fundamental endocrine output signal. Melatonin receptors are present in many anatomical sections of the eye, particularly the ocular surface and retina, and this cycle plays critical roles in maintaining ocular physiology. Disruptions in the timing system are closely associated with the pathogenesis of various ocular diseases, such as dry eye, delayed corneal wound healing, glaucoma, myopia, cataracts, and diabetic retinopathy. For instance, while glaucoma patients exhibit nocturnal intraocular pressure fluctuations and potential resistance to melatonin, exposure to high outdoor light has been found to reduce myopia development by influencing dopamine and melatonin release. Consequently, the 24-hour monitoring of circadian rhythms and the therapeutic use of melatonin analogues in the diagnosis and treatment of ocular diseases offer potent future targets for clinical approaches.
- 17 November 2021
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 29 (7-8) , 1438-1444
In Vivo Analysis and Comparison of Anterior Segment Structures of Both Eyes in Unilateral Herpetic Anterior Uveitis
Purpose: To compare the Schlemm's canal area (SCA) and to define iris features in patients with unilateral herpetic anterior uveitis (HAU) by using anterior segment spectral-domain optical coherence tomography (AS SD-OCT). Methods: Unilateral HAU cases that had been in complete remission for >= 3 months were included. Two investigators analyzed the iris features of HAU. SCA in both healthy (N), and affected eyes (HAU) were compared. Results: The mean age of the participants (n = 22) was 36.3 +/- 15 (17-70) years. The mean nasal and temporal (n-t) SCA was measured as 10,844 +/- 4806 mu m(2)and 8,772 +/- 3138 mu m(2)in HAU in comparison with 10,200 +/- 4,824 mu m(2)and 10,045 +/- 3,889 mu m(2)in N, respectively (p= .47 andp= .12, respectively). The most common iris features were the sectoral iridoplegia (100%) on biomicroscopy and the disorganization of the iris layers (DIL) (77%) on AS SD-OCT images. Conclusion: SCA found similar on both sides. DIL is the most common iris feature of affected eyes.
- 17 November 2021
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 29 (7-8) , 1438-1444
In Vivo Analysis and Comparison of Anterior Segment Structures of Both Eyes in Unilateral Herpetic Anterior Uveitis
Purpose: To compare the Schlemm's canal area (SCA) and to define iris features in patients with unilateral herpetic anterior uveitis (HAU) by using anterior segment spectral-domain optical coherence tomography (AS SD-OCT). Methods: Unilateral HAU cases that had been in complete remission for >= 3 months were included. Two investigators analyzed the iris features of HAU. SCA in both healthy (N), and affected eyes (HAU) were compared. Results: The mean age of the participants (n = 22) was 36.3 +/- 15 (17-70) years. The mean nasal and temporal (n-t) SCA was measured as 10,844 +/- 4806 mu m(2)and 8,772 +/- 3138 mu m(2)in HAU in comparison with 10,200 +/- 4,824 mu m(2)and 10,045 +/- 3,889 mu m(2)in N, respectively (p= .47 andp= .12, respectively). The most common iris features were the sectoral iridoplegia (100%) on biomicroscopy and the disorganization of the iris layers (DIL) (77%) on AS SD-OCT images. Conclusion: SCA found similar on both sides. DIL is the most common iris feature of affected eyes.
- 30 August 2021
- Published by Springer Nature in Eye
- Vol. 36 (10) , 2062-2066
Assessment of serum catalase, reduced glutathione, and superoxide dismutase activities and malondialdehyde levels in keratoconus patients
Background The aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced glutathione (GSH) and superoxide dismutase (SOD) and the level of the oxidative stress marker malondialdehyde (MDA) in serum. Methods The study included 50 patients diagnosed with keratoconus and 53 healthy age- and sex-matched control subjects. The keratoconus patients were grouped according to the four keratoconus stages based on the modified Krumeich keratoconus classification system. The CAT, GSH and SOD activities and MDA levels in the serum samples collected from the patient and control groups were compared. Results The mean serum CAT, GSH, SOD and MDA levels in the keratoconus group were determined to be 0.075 (0.074–0.078)U/L, 0.002 (0.001–0.006) mmol/ml, 1.56 (1.51–1.62)U/L and 1.69 (1.65–1.99) mmol/L, respectively, and those in the control group were determined to be 0.024 (0.013–0.037)U/L, 0.029 (0.018–0.049) mmol/ml, 4.13 (4.01–4.17) U/L and 0.74 (0.65–0.82) mmol/L. The serum GSH levels and SOD activity were significantly lower in the keratoconus group (p < 0.001 for both) than in the control group while the CAT activity and MDA levels were significantly higher (p < 0.001 for both). Conclusion The low serum GSH levels and SOD activity and the high CAT activity and MDA levels observed in this study suggest the presence of oxidative stress and inadequate antioxidant defence mechanisms in keratoconus patients. The studied parameters may offer auxiliary markers for use in the diagnosis and treatment of the keratoconus disease and in its potential therapeutic targets in the future.
- 30 August 2021
- Published by Springer Nature in Eye
- Vol. 36 (10) , 2062-2066
Assessment of serum catalase, reduced glutathione, and superoxide dismutase activities and malondialdehyde levels in keratoconus patients
Background The aim of this study was to investigate the relationship between keratoconus disease and the antioxidant activities of catalase (CAT), reduced glutathione (GSH) and superoxide dismutase (SOD) and the level of the oxidative stress marker malondialdehyde (MDA) in serum. Methods The study included 50 patients diagnosed with keratoconus and 53 healthy age- and sex-matched control subjects. The keratoconus patients were grouped according to the four keratoconus stages based on the modified Krumeich keratoconus classification system. The CAT, GSH and SOD activities and MDA levels in the serum samples collected from the patient and control groups were compared. Results The mean serum CAT, GSH, SOD and MDA levels in the keratoconus group were determined to be 0.075 (0.074–0.078)U/L, 0.002 (0.001–0.006) mmol/ml, 1.56 (1.51–1.62)U/L and 1.69 (1.65–1.99) mmol/L, respectively, and those in the control group were determined to be 0.024 (0.013–0.037)U/L, 0.029 (0.018–0.049) mmol/ml, 4.13 (4.01–4.17) U/L and 0.74 (0.65–0.82) mmol/L. The serum GSH levels and SOD activity were significantly lower in the keratoconus group (p < 0.001 for both) than in the control group while the CAT activity and MDA levels were significantly higher (p < 0.001 for both). Conclusion The low serum GSH levels and SOD activity and the high CAT activity and MDA levels observed in this study suggest the presence of oxidative stress and inadequate antioxidant defence mechanisms in keratoconus patients. The studied parameters may offer auxiliary markers for use in the diagnosis and treatment of the keratoconus disease and in its potential therapeutic targets in the future.